Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women

NCT03475706 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

438

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Solabegron immediate release tablets, low dose
DRUG: Solabegron immediate release tablets, high dose
DRUG: Matching Placebo

Sponsor

Velicept Therapeutics, Inc.